Receptor Surface Models

Perspectives in Drug Discovery and Design

Volumn 12, Issue , 1998, Pages 117-133

  Hahn, Mathew ^a   Rogers, David ^a  

^a ACCELRYS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0041288984     PISSN: 09282866     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1017082021150     Document Type: Article

References (51)

1. Hahn, M., Receptor surface models: 1. Definition and construction, J. Med. Chem., 38 (1995) 2080-2090.
2. Hahn, M.A. and Rogers, D., Receptor surface models: 2. Application to quantitative structure-activity relationship studies, J. Med. Chem., 38 (1995) 2091-2102.
3. Doweyko, A.M., The hypothetical active site lattice: An approach to modeling active sites from data on inhibitor molecules, J. Med. Chem., 31 (1988) 1396-1406.
4. Wiese, M., The hypothetical active-site lattice, In Kubinyi, H. (Ed.) 3D QSAR in drug design: Theory, Methods and Applications, ESCOM, Leiden, The Netherlands, 1993, pp. 80-116.
5. Kato Y., Inoue A., Yamada, M., Tomioka, N. and Itai, A., Automatic superposition of drug molecules based on their common receptor site, J. Comput. Assist. Mol. Design, 6 (1992) 475-486.
6. Kato, Y., Itai, A. and Iitaka, Y., A novel method for superimposing molecules and receptor mapping, Tetrahedron, 43 (1987) 5229-5236.
7. Srivastava, S., Richardson, W.W., Bradley, M.P. and Crippen, G.M., Three-dimensional receptor modeling using distance geometry and voronoi polyhedra, In Kubinyi, H. (Ed.), 3D QSAR in drug design: Theory, methods and applications, ESCOM, Leiden, The Netherlands, 1993, pp. 80-116.
8. Snyder, J.P., Rao, S.N., Koehler, K.F. and Vedani, A., Minireceptors and pseudoreceptors, In Kubinyi, H. (Ed.), 3D QSAR in drug design: Theory, methods and applications, ESCOM, Leiden, The Netherlands, 1993, pp. 336-354.
9. Cramer, R.D., Patterson, D.E. and Bunce, J.D., Comparative molecular field analysis (CoMFA): 1. Effect of shape on binding of steroids to carrier proteins, J. Am. Chem. Soc., 110 (1988) 5959-5967.
10. Cramer, R.D., DePriest, S.A., Patterson, D.E. and Hecht, D.E., The developing practice of comparative molecular field analysis, In Kubinyi, H. (Ed.), 3D QSAR in drug design: Theory, methods and applications, ESCOM, Leiden, The Netherlands, 1993, pp. 443-485.
11. Jain, A., Koile, K. and Chapman., D., Compass: Predicting biological activities from molecular surface properties - performance comparisons on a steroid benchmark, J. Med. Chem., 37 (1994) 2315-2327.
12. Walters, D.E. and Hinds, R.M., Genetically evolved receptor models: A computational approach to construction of receptor models, J. Med. Chem., 37 (1944) 2527-2535.
13. Kellogg, G.E., Kier, L.B., Gaillard, P. and Hall, L.H., E-state fields: Applications to 3D QSAR, J. Comput.-Aided Mol. Design, 10 (1996) 513-520.
14. Dunn III, W.J., Hopfinger, A.J., Catana, C. and Duraiswami, C., Solution of the conformation and alignment tensors for the binding of trimethoprim and its analogs to dihydrofotate reductase: 3D-quantitative structure-activity relationship study using molecular shape analysis - 3-way partial least-squares regression and 3-way factor analysis, J. Med. Chem., 39 (1996) 4825-4832.
15. Connolly, M.L., Analytical molecular surface calculation, J. Appl. Crystallogr., 16 (1983) 548-558.
16. Connolly, M.L., Solvent-accessible surface of proteins and nucleic acids, Science, 221 (1983) 709-713.
17. Purvis, G.D., On the use of isovalued surfaces to determine molecule shape and reaction pathways, J. Comput.-Aided Mol. Design, 5 (1991) 55-80.
18. Klein, T.E., Huang, C.C., Pettersen, E.F., Couch, O.S., Ferrin, T.E. and Langridge, R., A real-time malleable surface, J. Mol. Graphics, 8 (1990) 16-24.
19. Leicester, S.E., Finney, J.L. and Bywater, R.P., Description of molecular surface shape using Fourier descriptors, J. Mol. Graphics, 6 (1988) 104-108.
20. Grant, J. and Pickup, D., A Gaussian description of molecular shape, J. Phys. Chem., 99 (1995) 3503-3510.
21. Masek, B., Marchant, A. and Matthew, J., Molecular skins: A new concept for quantitative shape matching of a protein with its small molecule mimics, Proteins, 17 (1993) 193-202.
22. Masek, D., Marchant, A. and Matthew, J., Molecular shape comparison of angiotensin II antagonists, J. Med. Chem. Proteins, 36 (1993) 1230-1238.
23. Bohaceck, R. and McMartin, C., Definition and display of steric, hydrophobic, and hydrogen-bonding properties of ligand binding sites in proteins using Lee and Richards' accessible surface: Validation of a high-resolution graphical tool for drug design, J. Med. Chem., 35 (1992) 1671-1684.
24. Perkins, T., Mills, J. and Dean, P., Molecular surface-volume and property matching to superimpose flexible dissimilar molecules, J. Comput.-Aided Mol. Design, 9 (1995) 479-490.
25. Todeschini, R., Lasagni, M. and Marengo, E., New molecular descriptors for 2D and 3D structures, theory, J. Chemometrics, 8 (1994) 263-272.
26. Mezey, P., Three-dimensional topological aspects of molecular similarity, In Johnson, M. and Maggiora, G. (Eds.) Concepts and applications of molecular similarity, John Wiley, New York, 1990, 321-368.
27. Mezey, P., Shape in chemistry, VCH, New York, 1993.
28. VanDrie, J.H., 'Shrink-wrap' surfaces: A new method for incorporating shape into pharmacophore 3D database searching, J. chem. Inf. Comp. Sci., 37 (1997) 38-42.
29. Kearsely, S.K. and Smith, G.M., An alternative method for the alignment of molecular structures: Maximizing electrostatic and steric overlap, Tetrahedron Comput. Method., 3 (1990) 615-633.
30. Dammkoehler, R.A., Karasak, S.F., Berkely Shands, E.F. and Marshall, G.R., Constrained search of conformational hyperspace, J. Comput.-Aided Mol. Design, 3 (1989) 3-21.
31. Perkins, T.D. and Dean, P.M., An exploration of a novel strategy of superimposing several flexible molecules, J. Comput.-Aided Mol. Design, 7 (1993) 155-172.
32. Blaney, J.M. and Dixon, J.S., A good ligand is hard to find: Automatic docking methods, Perspectives in Drug Discovery and Design, 1 (1993) 301-319.
33. Martin, Y.C. and Bures, M.G., Danahar, E.A., DeLazzar, J., Lico, I. and Pavlik, P.A., A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists, J. Comput.-Aided Mol. Design, 7 (1993) 83.
34. Hoffmann, R. and Langer, T., Use of the CATALYST program as a new alignment tool for 3D QSAR, In Proceedings of the 10th European Symposium on Structure-Activity Relationships: QSAR and molecular modeling, Prous Science Publishers, Barcelona, Spain, 1995, pp. 466-469.
35. Barnum, D., Greene, J. and Smelie, A., Identification of common functional configurations, J. Chem. Inf. Comp. Sci., 36 (1996) 563-571.
36. Marshall, G.R., Binding site modeling of unknown receptors, In Kubinyi, H. (Ed.), 3D QSAR in drug design: Theory, methods and applications, ESCOM, Leiden, The Netherlands, 1993, pp. 80-116.
37. Wyvill, G., McPheeters, C. and Wyvill, B., Data structures for soft objects, The Visual Computer, 2 (1986) 227-234.
38. Goodford, P.J., A computational procedure for determining energetically favorable binding sites on biologically important macromolecules, J. Med. Chem., 28 (1985) 849-857.
39. Lorensen, W.E. and Cline, H.E., Marching cubes: A high resolution 3D surface construction algorithm, Computer Graphics (Proc. SIGGRAPH), 21 (1987) 163-169.
40. Heiden, W., Schlenkrich, M. and Brickman, J., Triangulation algorithms for the representation of molecular surface properties, J. Comput.-Aided Mol. Design, 4 (1990) 225-269.
41. Appelt, K., Cyrstal structures of HIV-1 protease-inhibitor complexes, Perspect. Drug Discov. Design, 1 (1993) 23-48.
42. Hopfinger, A.J., Nakata, Y. and Max, N., Quantitative structure-activity relationship of anthracycline antitumor activity and cardiac toxicity based upon intercalation calculations, In Pullman, B. (Ed.) Intermolecular forces, Reidel, Dordrecht, The Netherlands, 1981, p. 431.
43. Hopfinger, A.J. and Kawakami, Y., QSAR analysis of a set of benzothiopyranoindazole anti-cancer analogs based on their DNA intercalation properties as determined by molecular dynamics simulation, Anti-Cancer Drug Design, 7 (1992) 203-217.
44. Hoffmann, R. and Bourguignon, J.-J., Building a hypothesis for CCK-B antagonists using the CATALYST program, In Proceedings of the 10th European Symposium on Structure-Activity Relationships: QSAR and molecular modeling, Prous Science Publishers, Barcelona, Spain, 1995, 298-300.
45. Rogers, D. and Hopfinger, A.J., Application of genetic function approximation to quantitative structure-activity relationships and quantitative structure-property relationships, J. Chem. Inf. Comput. Sci.,34 (1994) 854-866.
46. Hahn, M., Three dimensional shape-based searching of conformationally flexible compounds, J. Chem. Inf. Comput. Sci., 37 (1997) 80-86.
47. This is ongoing work done by ourselves, Dr. Remy Hoffmann and Dr. Max Muir.
48. Hoffmann, R. and Sprague, P., Building a hypothesis for competitive inhibition of rat liver squalene expoxidase, CATALYST Application Note, 1995.
49. Rogers, D., Genetic function approximation: A genetic approach to developing quantitative structure-activity relationships models, In Proceedings of the 10th European Symposium on Structure-Activity Relationships: QSAR and molecular modeling, Prous Science Publishers, Barcelona, Spain, 1995, pp. 420-426.
50. Dunn III, W.J. and Rogers, D., Genetic partial least-squares in QSAR, In Devillers, J. (Ed.) Genetic Algorithms in Molecular Modeling, Academic Press, London, 1996, pp. 109-130.
51. Rogers, D. and Dunn III, W.J., Genetic partial least-squares, J. Comput.-Aided Mol. Design, (1997) (accepted).